198 filings
Page 5 of 10
424B4
98488f1dq
15 May 19
Prospectus supplement with pricing info
4:47pm
8-K
lbk1xut0c08flmmd0
8 May 19
Regulation FD Disclosure
8:50am
8-K
rnqoa
30 Apr 19
Evolus Reports First Quarter 2019 Financial Results
4:03pm
DEFA14A
5rmk2 v41ucvtf
29 Apr 19
Additional proxy soliciting materials
5:08pm
DEF 14A
zbkm cv5a
29 Apr 19
Definitive proxy
5:06pm
8-K
bq4 p2734o
26 Apr 19
Evolus Receives Positive CHMP Opinion for Nuceiva™ in the European Union
9:01am
EFFECT
dnhnrlf6v1w
16 Apr 19
Notice of effectiveness
12:15am
CORRESP
xpi3gjp522w7ss
11 Apr 19
Correspondence with SEC
12:00am
S-3/A
cz12ij
10 Apr 19
Shelf registration (amended)
6:33am
CORRESP
y5f2l3 0aao
10 Apr 19
Correspondence with SEC
12:00am
UPLOAD
ly42rx4v wyz6v9
4 Apr 19
Letter from SEC
12:00am
8-K
i5ds 3pd3fu
1 Apr 19
Evolus Provides Regulatory Update on Nuceiva™ in the European Union
9:05am
S-3
xjq6r
22 Mar 19
Shelf registration
4:56pm
8-K
2up4grwdg5hun91
18 Mar 19
Evolus Secures $100 Million Senior Debt Facility with Oxford Finance LLC
4:05pm
SC 13G
7am4lg70o 4un
14 Feb 19
Evolus, Inc.
4:28pm
SC 13G
g7yoa
12 Feb 19
Evolus, Inc.
9:38am
4
eqtk 0u5yckd55cyv
25 Jan 19
Evolus / Rui Avelar ownership change
8:22pm
4
jefhopl7tjif97
25 Jan 19
Evolus / Michael M. Jafar ownership change
8:22pm